Free Chat Friday (Every Friday) -- Our live chat room with stock and option alerts! Fridays, starting at 9:30 am, go to: https://goo.gl/O3l5KC use the password: freechatfriday

ARCA biopharma, Inc.
(NASDAQ : ABIO)

( )
ABIO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading ABIO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.00%155.431.1%$505.99m
GILDGilead Sciences, Inc.
0.00%64.560.9%$491.91m
REGNRegeneron Pharmaceuticals, Inc.
0.00%455.702.7%$466.21m
CELGCelgene Corporation
0.00%116.741.1%$419.11m
BIIBBiogen Inc.
0.00%252.971.2%$387.66m
ALXNAlexion Pharmaceuticals, Inc.
0.00%98.501.9%$350.94m
INCYIncyte Corporation
0.00%138.412.6%$272.84m
PBYIPuma Biotechnology, Inc.
0.00%78.0521.1%$202.70m
VRTXVertex Pharmaceuticals Incorporated
0.00%118.601.9%$199.99m
ILMNIllumina, Inc.
0.00%173.763.5%$196.01m
EXASExact Sciences Corporation
0.00%33.1928.0%$151.08m
AAgilent Technologies, Inc.
0.00%59.311.5%$135.90m
TSROTESARO, Inc.
0.00%153.1914.7%$110.52m
BMRNBioMarin Pharmaceutical Inc.
0.00%87.334.4%$104.59m
KITEKite Pharma, Inc.
0.00%74.9116.1%$102.44m

Company Profile

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company's business combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.